Hikma Pharmaceuticals PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
HKMPY Over the counter 2834 www.hikma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hikma Pharmaceuticals PLC

Hikma advances its epinephrine nasal spray with multi-market regulatory filings - Sep 10th, 2026 12:20 pm
Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets - Sep 5th, 2026 1:06 pm
Jefferies lifts Hikma target as CMO deal underpins growth story - Aug 25th, 2026 8:02 am
Citi sees Hikma discount as unwarranted after upgrade to forecasts - Aug 12th, 2026 7:56 am
Hikma boost as broker raises price target - Aug 10th, 2026 8:02 am
Hikma jumps 10% as brokers point to profit beat and undemanding rating - Aug 6th, 2026 3:30 am
Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi - Jul 23rd, 2026 6:17 am
Hikma recovery story still has further to run after recent rally, says Panmure - Jul 22nd, 2026 9:13 am
Citi starts Hikma at 'buy' with strategy reset offering compelling entry point - Jul 16th, 2026 5:02 am
Hikma comments on Supreme Court of the United States' unanimous decision in favour of Hikma - Jun 4th, 2026 3:39 pm
What Analysts Think Is Changing The Story For Hikma Pharmaceuticals (LSE:HIK) - Feb 6th, 2026 2:08 am
How the Narrative Around Hikma Pharmaceuticals Is Shifting After Recent Analyst Target Moves - Dec 15th, 2025 5:09 am